Green Cross Corporation (006280.KS)
KRW 168000.0
(-1.7%)
KRW 168000.0
(-1.7%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2643.31 Billion KRW | 4.66% |
| 2022 | 2525.53 Billion KRW | 2.57% |
| 2021 | 2462.14 Billion KRW | 14.44% |
| 2020 | 2151.39 Billion KRW | 9.8% |
| 2019 | 1959.29 Billion KRW | 13.69% |
| 2018 | 1723.4 Billion KRW | 1.16% |
| 2017 | 1703.58 Billion KRW | 9.86% |
| 2016 | 1550.61 Billion KRW | 9.57% |
| 2015 | 1415.12 Billion KRW | 6.37% |
| 2014 | 1330.35 Billion KRW | 20.47% |
| 2013 | 1104.26 Billion KRW | 15.7% |
| 2012 | 954.37 Billion KRW | 10.93% |
| 2011 | 860.35 Billion KRW | 16.06% |
| 2010 | 741.29 Billion KRW | 3.97% |
| 2009 | 713.02 Billion KRW | 29.79% |
| 2008 | 549.37 Billion KRW | 29.07% |
| 2007 | 425.63 Billion KRW | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 2729.52 Billion KRW | 1.66% |
| 2024 Q1 | 2684.97 Billion KRW | 1.58% |
| 2023 Q2 | 1284.16 Billion KRW | -49.75% |
| 2023 Q4 | 2643.31 Billion KRW | -1.29% |
| 2023 Q3 | 2677.75 Billion KRW | 108.52% |
| 2023 FY | 2643.31 Billion KRW | 4.66% |
| 2023 Q1 | 2555.3 Billion KRW | 1.18% |
| 2022 FY | 3592.06 Billion KRW | 2.57% |
| 2022 Q4 | 2525.53 Billion KRW | -3.09% |
| 2022 Q3 | 2606.15 Billion KRW | 3.74% |
| 2022 Q2 | 2512.09 Billion KRW | 0.22% |
| 2022 Q1 | 2506.48 Billion KRW | 1.8% |
| 2021 Q2 | 2248.42 Billion KRW | 1.11% |
| 2021 Q1 | 2223.83 Billion KRW | 3.37% |
| 2021 Q4 | 2462.14 Billion KRW | 6.82% |
| 2021 FY | 3496.83 Billion KRW | 14.44% |
| 2021 Q3 | 2304.99 Billion KRW | 2.52% |
| 2020 Q4 | 2151.39 Billion KRW | 1.58% |
| 2020 FY | 3241.2 Billion KRW | 9.8% |
| 2020 Q1 | 1945.62 Billion KRW | -0.7% |
| 2020 Q2 | 2049.49 Billion KRW | 5.34% |
| 2020 Q3 | 2117.89 Billion KRW | 3.34% |
| 2019 Q4 | 1959.29 Billion KRW | 4.18% |
| 2019 Q3 | 1880.75 Billion KRW | 3.45% |
| 2019 Q1 | 1769.04 Billion KRW | 2.65% |
| 2019 Q2 | 1817.99 Billion KRW | 2.77% |
| 2019 FY | 2773.86 Billion KRW | 13.69% |
| 2018 Q4 | 1723.4 Billion KRW | -1.05% |
| 2018 Q3 | 1741.71 Billion KRW | 1.3% |
| 2018 FY | 2628.59 Billion KRW | 1.16% |
| 2018 Q1 | 1704.48 Billion KRW | 0.05% |
| 2018 Q2 | 1719.31 Billion KRW | 0.87% |
| 2017 Q4 | 1703.58 Billion KRW | -0.76% |
| 2017 Q3 | 1716.64 Billion KRW | 3.25% |
| 2017 FY | 2560.69 Billion KRW | 9.86% |
| 2017 Q1 | 1544.19 Billion KRW | -0.41% |
| 2017 Q2 | 1662.63 Billion KRW | 7.67% |
| 2016 Q3 | 1613.07 Billion KRW | 2.89% |
| 2016 FY | 2249.27 Billion KRW | 9.57% |
| 2016 Q4 | 1550.61 Billion KRW | -3.87% |
| 2016 Q1 | 1444.59 Billion KRW | 2.08% |
| 2016 Q2 | 1567.73 Billion KRW | 8.52% |
| 2015 Q1 | 1375.11 Billion KRW | 3.36% |
| 2015 Q3 | 1386.62 Billion KRW | -3.36% |
| 2015 Q4 | 1415.12 Billion KRW | 2.06% |
| 2015 Q2 | 1434.78 Billion KRW | 4.34% |
| 2015 FY | 2058.66 Billion KRW | 6.37% |
| 2014 Q4 | 1330.35 Billion KRW | 1.05% |
| 2014 Q3 | 1316.58 Billion KRW | 8.82% |
| 2014 FY | 1790.87 Billion KRW | 20.47% |
| 2014 Q1 | 1154.03 Billion KRW | 4.51% |
| 2014 Q2 | 1209.83 Billion KRW | 4.84% |
| 2013 Q3 | 1105.8 Billion KRW | 2.97% |
| 2013 FY | 1624.12 Billion KRW | 15.7% |
| 2013 Q1 | 972.79 Billion KRW | 1.93% |
| 2013 Q2 | 1073.88 Billion KRW | 10.39% |
| 2013 Q4 | 1104.26 Billion KRW | -0.14% |
| 2012 Q2 | 862.26 Billion KRW | 2.36% |
| 2012 Q1 | 842.4 Billion KRW | -2.09% |
| 2012 FY | 1446.33 Billion KRW | 10.93% |
| 2012 Q4 | 954.37 Billion KRW | 0.73% |
| 2012 Q3 | 947.44 Billion KRW | 9.88% |
| 2011 FY | 4603.21 Billion KRW | 16.06% |
| 2011 Q4 | 860.35 Billion KRW | 0.67% |
| 2011 Q3 | 854.65 Billion KRW | 7.52% |
| 2011 Q2 | 794.89 Billion KRW | 2.4% |
| 2011 Q1 | 776.24 Billion KRW | 0.0% |
| 2010 Q1 | 680.34 Billion KRW | -4.58% |
| 2010 Q3 | 708.42 Billion KRW | 4.51% |
| 2010 FY | 4111.33 Billion KRW | 3.97% |
| 2010 Q2 | 677.88 Billion KRW | -0.36% |
| 2009 Q1 | 564.65 Billion KRW | 2.78% |
| 2009 Q3 | 611.4 Billion KRW | 5.27% |
| 2009 Q2 | 580.81 Billion KRW | 2.86% |
| 2009 Q4 | 713.02 Billion KRW | 16.62% |
| 2009 FY | 3345.83 Billion KRW | 29.79% |
| 2008 Q1 | 439.5 Billion KRW | 3.26% |
| 2008 Q4 | 549.37 Billion KRW | 7.64% |
| 2008 Q3 | 510.36 Billion KRW | 10.14% |
| 2008 Q2 | 463.38 Billion KRW | 5.43% |
| 2008 FY | 2783.54 Billion KRW | 29.07% |
| 2007 FY | 2431.62 Billion KRW | 0.0% |
| 2007 Q4 | 425.63 Billion KRW | 2.09% |
| 2007 Q1 | 337.7 Billion KRW | 0.0% |
| 2007 Q2 | 386 Billion KRW | 14.3% |
| 2007 Q3 | 416.9 Billion KRW | 8.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| ORIENT BIO Inc. | 96.98 Billion KRW | -2625.409% |
| Green Cross Holdings Corporation | 3737.7 Billion KRW | 29.28% |
| Green Cross Holdings Corporation | 2643.31 Billion KRW | 0.0% |
| Pharmicell Co., Ltd. | 99.19 Billion KRW | -2564.865% |
| GeneOne Life Science, Inc. | 151 Billion KRW | -1650.45% |
| Celltrion, Inc. | 19917.53 Billion KRW | 86.729% |
| Samsung Biologics Co.,Ltd. | 16046.19 Billion KRW | 83.527% |
| SK bioscience Co.,Ltd. | 1852.43 Billion KRW | -42.694% |
| SK Biopharmaceuticals Co., Ltd. | 723.17 Billion KRW | -265.517% |
| Prestige BioPharma Limited | 711.72 Billion KRW | -271.398% |